Catecholamines and self-stimulation: the action of amantadine and its interaction with amphetamine.
The antiparkinsonian drug amantadine HCl caused a dose-dependent depression of electrical self-stimulation, followed by a dose-dependent enhancement. Neither action was correlated with the differential effects of d- and l-amphetamine at different implantation sites. The initial depression was not prevented by pretreatment with anticholinergic or antiserotonergic agents nor by depression of catecholamine (CA) synthesis. The stimulant effects of amantadine and d-amphetamine summated but did not interact, response rates after d-amphetamine being augmented by pretreatment with amantadine except at intervals at which amantadine was by itself depressant. It is concluded that the initial effect of amantadien is caused by impulse-independent release of a pool of intraneuronal CA, causing dissociation between reinforcement signals and the rat's responses. This is followed by amphetamine-like facilitation of impulse-dependent release; the first action depresses performance, the second enhances it.
D000547:Amantadine / Q000008:administration & dosage / Q000494:pharmacology; D000661:Amphetamine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000096:biosynthesis; D003216:Conditioning, Operant / Q000187:drug effects; D003533:Cyproheptadine / Q000494:pharmacology; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D007267:Injections; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051381:Rats; D012653:Self Stimulation / Q000187:drug effects*; D013997:Time Factors
D002395:Catecholamines; D008781:Methyltyrosines; D003533:Cyproheptadine; D001285:Atropine; D000547:Amantadine; D000661:Amphetamine